SciRhom GmbH

https://www.scirhom.com

SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research conducted at Hospital for Special Surgery (HSS) and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academic and industry scientists with profound experience in antibody development. Since then, the company has developed first-in-class anti-iRhom2 antibodies and nominated a candidate for clinical studies. Four comprehensive patent families cover the anti-iRhom2 antibodies and iRhom2-target epitopes, securing exclusivity and protection against me-too drugs. To date, SciRhom has successfully acquired seed funding from the High-Tech Gruenderfonds (HTGF), Hospital for Special Surgery, and other institutional and private investors. *

	Start	2019-10-16 renamed
	Predecessor	SciMab GmbH
	Industry	drug development
	Industry 2	therapeutic antibody
	Person	Poth, Jan (SciRhom 202205– Managing Director (CEO) before Boehringer 201712 Therapeutic Area Head CNS + Immunology)
	Person 2	Ruhe, Jens (Scimab GmbH 201611– Managing Director)

	Region	Martinsried
	Country	Germany
	Street	19 Am Klopferspitz
	City	82152 Planegg
	Tel	+49-89-614-241230
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: SciRhom GmbH. (5/12/22). "Press Release: SciRhom Announces Addition to the Management Team". Munich.

		Record changed: 2023-12-30

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for SciRhom GmbH

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)